NOVELTY – Stable pharmaceutical composition comprises extract of Arrabidaea chica in controlled delivery system in form of microparticles, nanoparticles or liposome, and pharmaceutically acceptable additives. USE – Stable pharmaceutical composition used in preparation of a medicament and microparticles and nanoparticle delivery systems for treating tissue healing (all claimed). DETAILED DESCRIPTION – An INDEPENDENT CLAIM is included for a method for preparing pharmaceutical composition, which involves: (A) forming a controlled release system of Arrabidaea chica extract; (B) incorporating Arrabidaea chica extract with the vehicular system in order to maintain physical, chemical and pharmacological properties of components of the extract; and (C) embedding Arrabidaea chica extract in controlled release system with pharmaceutically acceptable additive in order to release active components in therapeutically effective quantities of for tissue healing.
A96 (Medical, dental, veterinary, cosmetic.); B07 (General – tablets, dispensers, catheters (excluding drainage and angioplasty), encapsulation etc, but not systems for administration of blood or saline or IV feeding etc.); B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.)